Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/10/2007
 
First Published:
9/15/2006
1.
Phase IV Randomized Pilot Study of Oxycodone Hydrochloride Versus Standard Three-Step Analgesic Therapy in Patients With Cancer-Related Pain
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Closed
18 and over
Other, Pharmaceutical / Industry
CRUK-ON/2003/1772
EU-20640, EUDRACT-2004-004235-66, NAPP-CRUK-ON/2003/1772, NCT00378937
2.
Phase III Chemotherapy with ARA-C/VCR/CTX/L-ASP/BLEO/PRED and VP-16 and CHOP (CTX/ADR/VCR/PRED) plus CNS Prophylaxis in Patients with High-Grade Lymphoma Who Are AIDS-Risk Group Members
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 to 60
LAC-USC-13NHL851
NCI-V85-0216
Last Modified:
12/18/2002
 
First Published:
7/1/1998
3.
Phase I/II Study of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Over 18
NCI
MSKCC-97124
NCI-H98-0014, NCT00003346
4.
Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and under
NCI
POG-7831
MDAR-319
Last Modified:
6/1/1997
5.
Phase II Chemotherapy with DCF Alternating with IFN-alpha A in Patients with Hairy Cell Leukemia (Summary Last Modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
BRMP-8509
NCI-85-C-193, NCI-T85-0282N, T85-0282
Last Modified:
1/1/1989
6.
Phase II Master Protocol for the Evaluation of New Treatments in Patients with Primary Liver Cancer --- IFN-beta(ser) and Menogaril (Summary Last Modified 01/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
any age
NCI
EST-1286
7.
Phase II Chemotherapy with BLEO plus Chemopotentiation with Trifluoperazine in Patients with Malignant Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 to 70
YALE-HIC-3839
NCI-V86-0093
8.
Double-Blind, Randomized, Multiple-Dose, Comparative Analgesic Efficacy and Safety Study of Ketorolac vs Acetaminophen plus Codeine, with a First-Dose Placebo Comparison, in Patients with Cancer Pain
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
18 and over
NCOG-0N841
NCOG-0N-84-1
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute